$DBHL

Deep Isolation Nuclear, Inc.

CIK:0001918080|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 1,319,000	$ 1,634,000	$ 2,766,000	$ 3,154,000
Cost of services (exclusive of depreciation shown separately below)	(612,000)	(756,000)	(1,293,000)	(1,418,000)
Gross profit	707,000	878,000	1,473,000	1,736,000
Operating expenses:
Selling, general and administrative expenses	2,746,000	2,215,000	5,586,000	3,208,000
Research and development	1,180,000	0	4,669,000	0
Depreciation and amortization expense	25,000	30,000	50,000	59,000
Total operating expenses	3,951,000	2,245,000	10,305,000	3,267,000
Loss from operations	(3,244,000)	(1,367,000)	(8,832,000)	(1,531,000)
Gain on insurance settlement	27,000	0	27,000	0
Other income	181,000	4,000	353,000	3,000
Net loss before income taxes	(3,036,000)	(1,363,000)	(8,452,000)	(1,528,000)
Provision for income taxes	0	0	0	1,000
Net loss	(3,036,000)	(1,363,000)	(8,452,000)	(1,529,000)
Other comprehensive income (loss):
Foreign currency translation adjustments	(15,000)	9,000	33,000	(40,000)
Total other comprehensive income (loss)	(15,000)	9,000	33,000	(40,000)
Other comprehensive loss	$ (3,051,000)	$ (1,354,000)	$ (8,419,000)	$ (1,569,000)
Net loss per common share – basic (in Dollars per share)	$ (0.05)	$ (0.03)	$ (0.15)	$ (0.04)
Net loss per common share – diluted (in Dollars per share)	$ (0.05)	$ (0.03)	$ (0.15)	$ (0.04)
Weighted average common shares outstanding - basic (in Shares)	57,660,684	42,151,949	57,684,662	41,447,903
Weighted average common shares outstanding - diluted (in Shares)	57,660,684	42,151,949	57,684,662	41,447,903

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities:
Net loss	$ (8,452)	$ (1,529)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	50	59
Interest expense	1	1
Stock based compensation	885	55
Gain on insurance settlement	(27)	0
Changes in operating assets and liabilities:
Accounts receivable	(32)	313
Allowance for credit losses	6	12
Contract assets	(252)	(57)
Other current assets	99	44
Other non current assets	61	0
Account payable	103	198
Contract liabilities	(150)	0
Accrued expenses	(484)	(125)
Other current liabilities	146	410
Operating lease right-of-use assets and lease liabilities	2	1
Net cash used in operating activities	(8,044)	(618)
Cash Flows from Investing Activities:
Purchases of property, plant and equipment	(74)	(31)
Proceeds from insurance on disposal of fixed asset	27	0
Net cash used in investing activities	(47)	(31)
Cash Flows from Financing Activities:
Payment of finance lease liability	(1)	(2)
Proceeds from exercise of stock options	4	394
Net cash provided by financing activities	3	392
Net change in cash and cash equivalents	(8,088)	(257)
Effect of exchange rate on cash and cash equivalents	33	(40)
Cash and cash equivalents:
Beginning of period	27,434	2,149
End of period	$ 19,379	$ 1,852

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash	$ 19,379,000	$ 27,434,000
Accounts receivable, net of allowance for credit losses of $124 and $118, respectively	465,000	439,000
Contract assets	527,000	275,000
Other current assets	573,000	672,000
Total current assets	20,944,000	28,820,000
Property, plant and equipment, net	194,000	128,000
Intangible assets, net	33,000	73,000
Finance lease right-of-use assets	9,000	11,000
Operating lease right-of-use assets	209,000	269,000
Goodwill	182,000	182,000
Other non-current assets	79,000	140,000
Total assets	21,650,000	29,623,000
Current liabilities:
Accounts payable	1,216,000	1,113,000
Accrued payroll	290,000	774,000
Contract liabilities	0	150,000
Finance lease liabilities, current	3,000	3,000
Operating lease liabilities, current	132,000	125,000
Other current liabilities	252,000	101,000
Total current liabilities	1,893,000	2,266,000
Finance lease liabilities, net of current portion	7,000	9,000
Operating lease liabilities, net of current portion	84,000	152,000
Total liabilities	1,984,000	2,427,000
Commitments and Contingencies (Note 16)
Stockholders’ Equity
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 57,647,613 and 57,542,113 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	6,000	6,000
Additional paid-in capital	60,345,000	59,456,000
Accumulated deficit	(40,955,000)	(32,503,000)
Accumulated other comprehensive income	270,000	237,000
Total stockholders’ equity	19,666,000	27,196,000
Total liabilities and stockholders’ equity	$ 21,650,000	$ 29,623,000